DXC Technology completes sale of health business to Dedalus

DXC Technology has completed the sale of its healthcare provider software business to the Dedalus Group.

The deal was originally announced in July 2020 and DXC said it expects to receive around £350million ($450million) from the deal.

Mike Salvino, president and CEO at DXC, said: “The completion of the sale of our healthcare provider software business strengthens our balance sheet and unlocks new value for our stakeholders.

“I would like to thank our people who are moving on to the Dedalus Group for their commitment and contributions over the years and for their focus on our customers during this process.”

The sale will propel European health IT and diagnostics specialist Dedalus into a leading market share position in the NHS due to DXC Technology’s large legacy installation base that gives it a footprint in many NHS trusts, a mixture of Lorenzo and older iSoft software.

Andrea Fiumicelli, CEO of Dedalus Group, added: “Dedalus’ vision is for a digitally enabled healthcare ecosystem where all stakeholders actively collaborate across the continuum of care to improve each citizen’s health outcomes.

“The acquisition by Dedalus is on par with our growth initiative strategy that began four years ago. Our expanded software solutions enable the integration of processes, workflows and applications in order to improve healthcare outcomes for each individual and for the population as a whole. At the core of our business is a constant focus and commitment to data security and to create and deliver innovation at scale.”